Search research articles
Contact Us
Filters
Showing results (61-70 of 76) with videos related to
Page
of 8
Sort By:
Chembiochem : a European Journal of Chemical Biology
|
May 15, 2008
Alpha-lactosylceramide as a novel "sugar-capped" CD1d ligand for natural killer T cells: biased cytokine profile and therapeutic activities
Wenpeng Zhang, Xincheng Zheng, Chengfeng Xia, et al.
Journal of Medicinal Chemistry
|
July 5, 2007
Modification of the ceramide moiety of isoglobotrihexosylceramide on its agonist activity in stimulation of invariant natural killer T cells
Chengfeng Xia, Jens Schümann, Rossy Emmanuel, et al.
Bioorganic & Medicinal Chemistry Letters
|
February 7, 2006
Synthesis and biological evaluation of alpha-galactosylceramide (KRN7000) and isoglobotrihexosylceramide (iGb3)
Chengfeng Xia, Qingjia Yao, Jens Schümann, et al.
Bioorganic & Medicinal Chemistry
|
June 30, 2009
Characterization and synthetic application of a novel beta1,3-galactosyltransferase from Escherichia coli O55:H7
Xian-wei Liu, Chengfeng Xia, Lei Li, et al.
Organic Letters
|
March 25, 2010
Acortatarins A and B, two novel antioxidative spiroalkaloids with a naturally unusual morpholine motif from Acorus tatarinowii
Xiao-Gang Tong, Li-Li Zhou, Yue-Hu Wang, et al.
The Journal of Organic Chemistry
|
November 21, 2007
Synthesis and structure-activity relationship study of isoglobotrihexosylceramide analogues
Wenlan Chen, Chengfeng Xia, Jinhua Wang, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
March 3, 2009
Remodeling bacterial polysaccharides by metabolic pathway engineering
Wen Yi, Xianwei Liu, Yanhong Li, et al.
Molecular Cancer Therapeutics
|
June 10, 2011
Enhanced antitumor effects by chemical modified IGb3 analogues
Zhixia Zhou, Cai Zhang, Chengfeng Xia, et al.
Journal of Medicinal Chemistry
|
October 12, 2017
Design, Synthesis, and Biological Activities of Vibsanin B Derivatives: A New Class of HSP90 C-Terminal Inhibitors
Li-Dong Shao, Jia Su, Baixin Ye, et al.
Vaccine
|
February 10, 2009
Nanoparticle formulated alpha-galactosylceramide activates NKT cells without inducing anergy
Prakash Thapa, Guodong Zhang, Chengfeng Xia, et al.
Page
of 8
Search research articles
Search
Showing results (61-70 of 76) with videos related to
Sort By:
Page
of 8
Chembiochem : a European Journal of Chemical Biology
|
May 15, 2008
Alpha-lactosylceramide as a novel "sugar-capped" CD1d ligand for natural killer T cells: biased cytokine profile and therapeutic activities
Wenpeng Zhang, Xincheng Zheng, Chengfeng Xia, et al.
Journal of Medicinal Chemistry
|
July 5, 2007
Modification of the ceramide moiety of isoglobotrihexosylceramide on its agonist activity in stimulation of invariant natural killer T cells
Chengfeng Xia, Jens Schümann, Rossy Emmanuel, et al.
Bioorganic & Medicinal Chemistry Letters
|
February 7, 2006
Synthesis and biological evaluation of alpha-galactosylceramide (KRN7000) and isoglobotrihexosylceramide (iGb3)
Chengfeng Xia, Qingjia Yao, Jens Schümann, et al.
Bioorganic & Medicinal Chemistry
|
June 30, 2009
Characterization and synthetic application of a novel beta1,3-galactosyltransferase from Escherichia coli O55:H7
Xian-wei Liu, Chengfeng Xia, Lei Li, et al.
Organic Letters
|
March 25, 2010
Acortatarins A and B, two novel antioxidative spiroalkaloids with a naturally unusual morpholine motif from Acorus tatarinowii
Xiao-Gang Tong, Li-Li Zhou, Yue-Hu Wang, et al.
The Journal of Organic Chemistry
|
November 21, 2007
Synthesis and structure-activity relationship study of isoglobotrihexosylceramide analogues
Wenlan Chen, Chengfeng Xia, Jinhua Wang, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
March 3, 2009
Remodeling bacterial polysaccharides by metabolic pathway engineering
Wen Yi, Xianwei Liu, Yanhong Li, et al.
Molecular Cancer Therapeutics
|
June 10, 2011
Enhanced antitumor effects by chemical modified IGb3 analogues
Zhixia Zhou, Cai Zhang, Chengfeng Xia, et al.
Journal of Medicinal Chemistry
|
October 12, 2017
Design, Synthesis, and Biological Activities of Vibsanin B Derivatives: A New Class of HSP90 C-Terminal Inhibitors
Li-Dong Shao, Jia Su, Baixin Ye, et al.
Vaccine
|
February 10, 2009
Nanoparticle formulated alpha-galactosylceramide activates NKT cells without inducing anergy
Prakash Thapa, Guodong Zhang, Chengfeng Xia, et al.
Page
of 8